Recruiting

B2RAD

Sponsor:

Sohail Rao

Code:

NCT05292430

Conditions

Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

Specimen Collection

Study Details

Brief summary:

Recent advances in understanding the molecular and cellular pathology of many diseases have resulted in direct benefit to today's patients. The translational research studies that have led to these advances relied on an integrated model of clinical and non-clinical laboratory investigations based on the analysis of human biospecimens that lead directly to drug discovery, drug validation, novel detection assays, and prognostic marker discovery. Translational research provides a unique mechanism to address questions specific to particular tumor or other disease types, biological modifiers and/or mechanisms of action that are essential for the advancement of healthcare. Specimens are to be collected from subjects who are having or have had a surgical or medical procedure (such as fluid or tissue removed, a biopsy or a blood or bone marrow draw). Any subject in which the primary diagnosis of disease was made within the DHR Health System and Any subject choosing to give consent for participation will be included

Conditions

Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw

Study ID

NCT05292430

Start date

Jan 22, 2020

Status verified date

Mar, 2022

Completion date

Dec, 2022

Anticipated

Primary completion date

Dec, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Any subject choosing to give consent for participation will be included.
2. Any subject in which the primary diagnosis of cancer was made at the DHR Health System.

Exclusion Criteria:

1. Any subject deemed unable to provide legally effective consent.
2. Any pediatric subject where the subject does not freely give his or her assent or where his or her parent/guardian does not give consent.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

Biobank

Specimens are to be collected from subjects who are having or have had a surgical or medical procedure (such as fluid or tissue removed, a biopsy or a blood or bone marrow draw). Any subject in which the primary diagnosis of disease was made within the DHR Health System and Any subject choosing to give consent for participation will be included.

Interventions

Specimen Collection

collection of diseased and non-diseased tissue, blood, and other body fluids

Primary outcome measure

  • Collection of diseased and non-diseased tissue, blood, and other body fluids [ Time Frame: once ]

Central Contacts and Locations

Central contacts

Sohail Rao, MD

956-362-2387s.rao@dhr-rgv.com

Monica Betancourt-Garcia, MD

956-362-3223m.betancourt@dhr-rgv.com

Locations

DHR Health Institute for Research and Development

Recruiting

Edinburg, Texas, United States, 78539

Contacts

Sohail Rao, MD

956-362-2387s.rao@dhr-rgv.com

Monica Betancourt-Garcia, MD

9563623223m.betancourt@dhr-rgv.com

DHR Health

Recruiting

Edinburg, Texas, United States, 78539

Contacts

Sohail Rao, MD

956-362-2387s.rao@dhr-rgv.com

Monica Betancourt-Garcia, MD

956-362-3223m.betancourt@dhr-rgv.com

More Information

Sponsor

Sohail Rao

Last update posted

Mar 23, 2022

Last verified

Mar, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Sohail Rao on 2022-03-23.